G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.
about
Regulation of Bim in Health and DiseaseTransient and Prolonged Response of Chicken Cecum Mucosa to Colonization with Different Gut MicrobiotaThe unique C- and N-terminal sequences of Metallothionein isoform 3 mediate growth inhibition and Vectorial active transport in MCF-7 cells.Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation.IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells.Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland.IFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function.Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells.Gene expression profile of compressed primary human cementoblasts before and after IL-1β stimulation.Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth.ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression.Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins.A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication
P2860
Q26781203-BE1617B1-DF73-4DE9-AB3C-B28022571865Q27320980-4A98A90C-D77E-4885-A2F1-186F1CF497F4Q33730545-2571636E-C133-4B4A-90E6-1AD242ACA506Q35048276-A002AF5D-9550-4848-9265-9EC91E7871B3Q35921378-E9C8AF14-0FC9-4BC4-9130-C4DA7D762014Q36270505-8021BF03-D74C-40B2-BF25-47E763A7E280Q36632263-D36091EC-E0ED-4142-975E-D6D297B07CF9Q36662334-3C3A6154-5404-4357-89C5-7E113EAA1154Q37404536-20DDF7B3-8AB5-4055-B091-7E94821406E3Q38481176-B0E1DB23-2880-44FB-BD76-B7014FAAE097Q38780897-EFC8E80F-5BBE-4063-82C4-357E59756789Q39173954-F5D825F4-B9FF-4048-9ED9-390B99484D1EQ39313078-AEF9FC97-7370-456F-AE1C-1DF85B9C421CQ46244013-DA7EDAB1-5565-483F-92A0-E8C605A09ACFQ51457076-D9ED2346-ADDF-458F-90B1-25310EAF2B3BQ57822854-5741376B-2CAF-4741-980A-752D9CF061EA
P2860
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@en
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@nl
type
label
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@en
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@nl
prefLabel
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@en
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
G1P3, an interferon- and estro ...... oor outcomes in breast cancer.
@en
P2093
B S Jacobs
E C Borden
E Downs-Kelly
P Evangelista
V Cheriyath
P2860
P2888
P304
P356
10.1038/ONC.2011.393
P407
P577
2011-09-26T00:00:00Z